NeoDoppler ultrasound probe
Preterm children have large fluctuations in blood flow in the brain, increasing the risk of brain damage substantially.
The NeoDoppler ultrasound probe provides a direct continuous measurement of cerebral blood flow that allows clinicians to act early to prevent brain damage by timing medical interventions.
NeoDoppler is a new type of non-invasive ultrasound probe that connects via a cord to a device that transmits and receives ultrasound. The probe can measure blood flow at many depths simultaneously and covers a relatively large area. The technology is operator independent and does not require ultrasound expertise.
The probe can sit for hours and days, monitoring the blood flow continuously through a display unit. An especially important area of application is sick newborns and infants born prematurely, where there is a risk of brain damage, inventor Professor Hans Torp explains.
Direct and continuous measurement of cerebral blood flow will give us the opportunity to optimise the factors that we know affect cerebral blood flow, thus ensuring stable blood supply and oxygen saturation of brain tissue in the most critical phase after preterm birth.
Based on the continuous measurements, respiratory settings, treatment of low blood pressure and response to pain and stress can be tailored to reduce the risk of brain damage. The potential for reducing the incidence of brain damage will be great with such a new ultrasound-based method.
Neodoppler is commercialised through the company Cimon Medical.